B40

(2S)-N-methyl-1-phenylpropan-2-amine

Created: 2009-03-19
Last modified:  2021-03-01

Find related ligands:

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count1
Bond Count26
Aromatic Bond Count6
2D diagram of B40

Chemical Component Summary

Name(2S)-N-methyl-1-phenylpropan-2-amine
SynonymsMethamphetamine
Systematic Name (OpenEye OEToolkits)(2S)-N-methyl-1-phenyl-propan-2-amine
FormulaC10 H15 N
Molecular Weight149.233
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04N(C(Cc1ccccc1)C)C
SMILESCACTVS3.341CN[CH](C)Cc1ccccc1
SMILESOpenEye OEToolkits1.5.0CC(Cc1ccccc1)NC
Canonical SMILESCACTVS3.341 CN[C@@H](C)Cc1ccccc1
Canonical SMILESOpenEye OEToolkits1.5.0 C[C@@H](Cc1ccccc1)NC
InChIInChI1.03 InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1
InChIKeyInChI1.03 MYWUZJCMWCOHBA-VIFPVBQESA-N

Drug Info: DrugBank

DrugBank IDDB01577 
NameMetamfetamine
Groups
  • approved
  • withdrawn
  • illicit
DescriptionMetamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse. The FDA withdrew its approval for the use of all parenteral drug products containing methamphetamine hydrochloride, a metamfetamine salt.[L43942]
Synonyms
  • Methamphetaminum
  • d-deoxyephedrine
  • Metamfetamine hydrochloride
  • Metamfetamine tartrate
  • d-N-methylamphetamine
Brand Names
  • Methamphetamine Hydrochloride
  • Desoxyn
IndicationFor the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.
Categories
  • Adrenergic Agents
  • Adrenergic Agonists
  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Adrenergic Uptake Inhibitors
ATC-CodeN06BA03
CAS number537-46-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Sodium-dependent dopamine transporterMSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...unknownnegative modulator
Sodium-dependent serotonin transporterMETTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV...unknownnegative modulator
Sodium-dependent noradrenaline transporterMLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...unknownnegative modulator
Synaptic vesicular amine transporterMALSELALVRWLQESRRSRKLILFIVFLALLLDNMLLTVVVPIIPSYLYS...unknowninhibitor
Chromaffin granule amine transporterMLRTILDAPQRLLKEGRASRQLVLVVVFVALLLDNMLFTVVVPIVPTFLY...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1201201
PubChem 10836
ChEMBL CHEMBL1201201
ChEBI CHEBI:6809
CCDC/CSD MEXVUI, FAKHOO, CIVFOC10, MIYCUT, OKIPAZ, OKIPED, BAVDIL, BAVDOR, BAVFAF, OSEHEC
COD 2218183